Lv5
1178 积分 2022-02-15 加入
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
2天前
已完结
Oncolytic virus VG161 in refractory hepatocellular carcinoma
9天前
已完结
Publisher Correction: Oncolytic virus VG161 in refractory hepatocellular carcinoma
9天前
已完结
Real-world Hepatobiliary Toxicity After Bispecific T-Cell Engager Therapy: A 10-Year Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System and the World Health Organization's Global Individual Case Safety Report Database
16天前
已完结
An unexpected cause of acute liver failure following CAR T-cell therapy
16天前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
1个月前
已完结
Systemic lupus erythematosus
3个月前
已完结
Advances in the treatment of systemic lupus erythematosus
4个月前
已完结
Optimization of CAR T-cell dose: a debated unresolved issue
4个月前
已完结
Novel strategies to manage CAR-T cell toxicity
4个月前
已完结
皖公网安备34019202002308
